Effects of Drospirenone–Ethinylestradiol and/or Metformin on CD4+CD28null T Lymphocytes Frequency in Women With Hyperinsulinemia Having Polycystic Ovary Syndrome

Differential Pathways Govern CD4+CD28- T Cell Proinflammatory and Effector Responses in Patients with Coronary Artery Disease

(2014) B. Zal et al.   JOURNAL OF IMMUNOLOGY

Ethinyl estradiol-drospirenonevsethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome

(2012) Nese Cinar et al.   CLINICAL ENDOCRINOLOGY

CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes

(2012) Francesca Moro et al.   FERTILITY AND STERILITY

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

(2011) Maria F. Gangale et al.   CLINICAL ENDOCRINOLOGY

Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus

(2011) Simona Giubilato et al.   EUROPEAN HEART JOURNAL

CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome

(2011) Giampaolo Niccoli et al.   FERTILITY AND STERILITY

Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome

(2011) Paulina A. Essah et al.   FERTILITY AND STERILITY

Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients

(2010) M. G. H. Betjes et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review

(2009) Stefano Palomba et al.   ENDOCRINE REVIEWS

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

(2009) Evanthia Diamanti-Kandarakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

(2009) Franca Fruzzetti et al.   FERTILITY AND STERILITY

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

(2009) Lisa Moran et al.   HUMAN REPRODUCTION UPDATE

Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications

(2009) Ronald B. Goldberg   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Use of metformin in polycystic ovary syndrome

(2008) Ruchi Mathur et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

CD4+CD28null T cells in coronary artery disease: when helpers become killers

(2008) I. E. Dumitriu et al.   CARDIOVASCULAR RESEARCH

Neopterin, CD4+CD28− lymphocytes and the extent and severity of coronary artery disease

(2008) Hannes F. Alber et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY